allantoin has been researched along with Lymphoma, Non-Hodgkin in 2 studies
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kattygnarath, D | 1 |
| Mounier, N | 1 |
| Madelaine-Chambrin, I | 1 |
| Gourmel, B | 1 |
| Le Bricon, T | 1 |
| Gisselbrecht, C | 1 |
| Faure, P | 1 |
| Houzé, P | 1 |
| Leach, M | 1 |
| Parsons, RM | 1 |
| Reilly, JT | 1 |
| Winfield, DA | 1 |
2 other studies available for allantoin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Quantification of urinary allantoin by capillary zone electrophoresis during recombinant urate oxydase (rasburicase) therapy.
Topics: Allantoin; Biomarkers; Electrophoresis, Capillary; Humans; Lymphoma, Non-Hodgkin; Recombinant Protei | 2006 |
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
Topics: Aged; Allantoin; Antimetabolites, Antineoplastic; Diuresis; Drug Evaluation; Female; Humans; Kidney | 1998 |